Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc. (COLL) Stock Overview

Explore Collegium Pharmaceutical, Inc.’s financial performance, market position, analyst ratings, and future outlook.

COLL●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$24.81
$0.34(1.39%)
U.S. Market opens in 12h 59m

Collegium Pharmaceutical, Inc. (COLL)

Meyka AI Score

Z

Key Financials

Market Cap771M
P/E Ratio20.18
EPS (TTM)$7.97
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$33.18
3 Months$22.74
1 Year Target$37.81

COLL Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Collegium Pharmaceutical, Inc. (NASDAQ: COLL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Collegium Pharmaceutical, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of COLL on the NASDAQ shows an RSI of 60.95, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $37.81 for the NASDAQ listing.

Key metrics behind Collegium Pharmaceutical, Inc.'s NASDAQ-traded stock include a P/E ratio of 20.18 and a market capitalization of 771M. Combined with our AI analysis, these give both institutional and retail investors a clear view of COLL on the NASDAQ.

Price Performance (NASDAQ: COLL)

1-Day Change
1.39%
5-Day Change
3.12%
1-Month Change
12.31%
3-Month Change
-4.50%
6-Month Change
-30.72%
Year-to-Date (YTD) Change
-46.41%
1-Year Change
-44.67%
3-Year Change
-1.51%
5-Year Change
23.31%
All-Time (Max) Change
101.87%

Contact Information

https://www.collegiumpharma.com
781 713 3699
100 Technology Center Drive, Stoughton, MA, 02072

Company Facts

4,230 Employees
IPO DateMay 7, 2015
CountryUS
Actively Trading

Frequently Asked Questions